Statistics for Cellectar Biosciences (id:6114 CLRB)

Valuation metrics

Market cap

86.81M

Enterprise value

69.89M

Trailing P/E (ttm)

-0.51

Forward P/E

-0.76

PEG ratio

-0.76

Price/Sales (ttm)

Price/Book (mrq)

16.85

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.47

Overview

Shares outstanding

40.57M

Float

29.60M

Shares short

1.96M

% Held by insiders

0.03%

% Held by institutions

0.31%

Average volume (10 days)

246.00K

Average volume (90 days)

Price summary

52-Week low

1.39

52-Week high

4.45

52-Week change

-32.91%

Beta

1.01

50-Day moving average

2.08

200-Day moving average

2.82

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

July 17th, 2018

Ex-dividend date

Last split factor

2:1

Last split date

July 22th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-166.00%

Return on equity

-796.67%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-47,400,856.00

Net income to common (ttm)

-52,962,856.00

Diluted EPS (ttm)

-2.43

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

25.87M

Total cash per share (mrq)

0.64

Total debt (mrq)

530.86K

Total Debt/Equity (mrq)

3.86

Current ratio (mrq)

184.00%

Book value per share (mrq)

0.13

Cash flow

Cash flow statement

-45,166,224.00

Levered free cash flow (LFCF)

-20,477,556.00